Incisional Biopsy Versus Core-needle Biopsy in Bone Tumors Analysis
Condition(s) studied
Investigational drug(s) / intervention(s)
incisional or core-needle biopsy for tumor diagnosis: incisional or core-needle biopsy for tumor diagnosis
Study summary
The investigators will collect data of patients with high suspicion of malignant bone tumor based on radiological imaging who underwent/will undergo both core needle biopsy and incisional biopsy for diagnostic confirmation by histological examination.
From 01/01/2015 to the approval date of this study: retrospective study; from the approval date of this study to 31/12/2027: prospective study. the investigators expect to collect data from a total of 72 patients: approximately 30 patients for the retrospective study and 42 for the prospective study. A review will be made from the medical records, radiological imaging, and histological data of partecipants.
Eligibility
Primary outcome measure(s)
- compare the agreement between core needle biopsy and incisional biopsy, based on Cohen's kappa coefficient. — through study completion, an average of 3 year
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Irccs Istituto Ortopedico Rizzoli | Bologna | Emilia-Romagna |
More Istituto Ortopedico Rizzoli trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07113301 on ClinicalTrials.gov ↗ ← All trials in Italy